CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Progress Toward Regional Measles Elimination — Worldwide, 2000–2020
-
11 12 2021
-
-
Source: MMWR Morb Mortal Wkly Rep. 70(45):1563-1569
Details:
-
Alternative Title:MMWR Morb Mortal Wkly Rep
-
Personal Author:
-
Description:In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles| in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030)| uses measles incidence as an indicator of the strength of immunization systems. The Measles-Rubella Strategic Framework 2021-2030| and the Measles Outbreaks Strategic Response Plan 2021-2023** are aligned with the IA2030 and highlight robust measles Surveillance systems to document immunity gaps, identify root causes of undervaccination, and develop locally tailored solutions to ensure administration of 2 doses of measles-containing vaccine (MCV) to all children. This report describes progress toward World Health Assembly milestones and measles elimination objectives during 2000-2020 and updates a previous report (2). During 2000-2010, estimated MCV first dose (MCV1) coverage increased globally from 72% to 84%, peaked at 86% in 2019, but declined to 84% in 2020 during the COVID-19 pandemic. All countries conducted measles Surveillance, although fewer than one third achieved the sensitivity indicator target of ≥2 discarded| cases per 100,000 population in 2020. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, rebounded to 120 in 2019, before falling to 22 in 2020. During 2000-2020, the annual number of estimated measles deaths decreased 94%, from 1,072,800 to 60,700, averting an estimated 31.7 million measles deaths. To achieve regional measles elimination targets, enhanced efforts are needed to reach all children with 2 MCV doses, implement robust Surveillance, and identify and close immunity gaps.
-
Subjects:
-
Source:
-
Pubmed ID:34758014
-
Pubmed Central ID:PMC8580203
-
Document Type:
-
Name as Subject:
-
Volume:70
-
Issue:45
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: